Pegvaliase | m-entrepreneurship.com

Product Name :
Pegvaliase

Search keywords :
Phenylalanine ammonia-lyase

drugId :
null

Target Vo:
Phenylalanine ammonia-lyase

Target Vo Short Name :
Ava-3988

Moa_Name:
Phenylalanine ammonia-lyase replacements

First Approval Country :
United States

First Approval Date Filter:
2018

Origin Company_Name :
Biomarin Pharmaceutical Inc

Active Company_Name :
Biomarin International Ltd

Active Indication_Name:
Phenylketonurias

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Zolbetuximab Protocol
Ranibizumab (anti-VEGF) supplier
PLK1 Antibody: PLK1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 68 kDa, targeting to PLK1. It can be used for WB, ICC/IF, IP assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts